C
Clinomics Inc
KOSDAQ:352770
Clinomics Inc
KOSDAQ:352770
Price:
5 250
KRW
-20.63%
Market Closed
Market Cap:
₩13.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Clinomics Inc
KOSDAQ:352770
|
KR |
|
A
|
Arihant Tournesol Ltd
BSE:526125
|
IN |
|
ZoomInfo Technologies Inc
NASDAQ:GTM
|
US |
|
Xuchang Yuandong Drive Shaft Co Ltd
SZSE:002406
|
CN |
|
A
|
Amazon.com Inc
XHAM:AMZ
|
US |
|
I
|
InnoCare Optoelectronics Corp
TWSE:6861
|
TW |
|
Newpark Resources Inc
NYSE:NR
|
US |
|
P
|
Pommersche Provinzial-Zuckersiederei AG
XBER:PPZ
|
DE |
|
Hornbach Baumarkt AG
LSE:0ENN
|
DE |
|
N
|
Nissan Motor Co Ltd
XHAM:NISA
|
JP |
|
Z
|
Zhejiang Kingland Pipeline and Technologies Co Ltd
SZSE:002443
|
CN |
|
S
|
Sejin Heavy Industries Co Ltd
KRX:075580
|
KR |
Balance Sheet
Balance Sheet Decomposition
Clinomics Inc
Clinomics Inc
Balance Sheet Decomposition is not available for
Clinomics Inc
Clinomics Inc
Balance Sheet
Clinomics Inc
Clinomics Inc
Currency: KRW
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
636
|
2 941
|
2 572
|
12 833
|
16 836
|
8 599
|
11 046
|
1 605
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
14
|
3
|
2
|
|
| Cash Equivalents |
636
|
2 941
|
2 572
|
12 833
|
16 836
|
8 585
|
11 043
|
1 603
|
|
| Short-Term Investments |
0
|
0
|
14 500
|
17 050
|
27 011
|
9 050
|
950
|
720
|
|
| Total Receivables |
525
|
457
|
1 596
|
1 902
|
28 128
|
30 691
|
1 914
|
1 254
|
|
| Accounts Receivables |
525
|
232
|
1 303
|
1 604
|
27 231
|
29 732
|
1 157
|
447
|
|
| Other Receivables |
0
|
225
|
293
|
298
|
897
|
959
|
758
|
808
|
|
| Inventory |
145
|
89
|
824
|
676
|
1 615
|
2 786
|
2 386
|
0
|
|
| Other Current Assets |
74
|
518
|
905
|
765
|
835
|
969
|
1 903
|
3 030
|
|
| Total Current Assets |
1 380
|
4 005
|
20 397
|
33 225
|
74 425
|
52 095
|
18 199
|
6 609
|
|
| PP&E Net |
1 051
|
2 697
|
6 211
|
9 467
|
19 957
|
28 522
|
28 284
|
35 495
|
|
| PP&E Gross |
0
|
2 697
|
6 211
|
9 467
|
19 957
|
28 522
|
28 284
|
35 495
|
|
| Accumulated Depreciation |
0
|
550
|
1 256
|
2 915
|
5 383
|
8 826
|
18 630
|
27 593
|
|
| Intangible Assets |
76
|
143
|
272
|
366
|
595
|
809
|
2 532
|
223
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
3 423
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
481
|
10 329
|
628
|
|
| Long-Term Investments |
0
|
0
|
0
|
97
|
6 934
|
13 921
|
11 396
|
10 091
|
|
| Other Long-Term Assets |
0
|
502
|
56
|
605
|
677
|
1 276
|
320
|
512
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
3 423
|
0
|
|
| Total Assets |
2 507
N/A
|
7 347
+193%
|
26 936
+267%
|
43 760
+62%
|
102 587
+134%
|
97 104
-5%
|
74 484
-23%
|
53 558
-28%
|
|
| Liabilities | |||||||||
| Accounts Payable |
286
|
88
|
69
|
215
|
74
|
54
|
510
|
348
|
|
| Accrued Liabilities |
0
|
40
|
164
|
190
|
626
|
459
|
304
|
846
|
|
| Short-Term Debt |
200
|
500
|
0
|
0
|
0
|
0
|
6 460
|
6 029
|
|
| Current Portion of Long-Term Debt |
0
|
301
|
491
|
322
|
14 008
|
17 377
|
8 332
|
24 304
|
|
| Other Current Liabilities |
55
|
687
|
1 535
|
1 807
|
24 514
|
18 792
|
8 676
|
13 602
|
|
| Total Current Liabilities |
541
|
1 616
|
2 259
|
2 533
|
39 222
|
36 681
|
24 282
|
44 433
|
|
| Long-Term Debt |
285
|
619
|
18 756
|
495
|
2 798
|
6 105
|
9 201
|
2 672
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
476
|
5
|
331
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
259
|
365
|
28
|
|
| Other Liabilities |
292
|
605
|
871
|
812
|
1 477
|
1 116
|
1 673
|
974
|
|
| Total Liabilities |
1 118
N/A
|
2 840
+154%
|
21 886
+671%
|
3 841
-82%
|
43 974
+1 045%
|
44 166
+0%
|
35 852
-19%
|
48 108
+34%
|
|
| Equity | |||||||||
| Common Stock |
417
|
889
|
907
|
1 332
|
1 347
|
1 362
|
3 198
|
3 889
|
|
| Retained Earnings |
2 319
|
4 658
|
10 432
|
23 286
|
7 318
|
15 834
|
58 005
|
104 332
|
|
| Additional Paid In Capital |
3 263
|
9 178
|
15 491
|
62 962
|
64 608
|
65 294
|
90 485
|
101 140
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
100
|
421
|
|
| Treasury Stock |
0
|
909
|
909
|
909
|
909
|
909
|
905
|
905
|
|
| Other Equity |
29
|
7
|
8
|
180
|
885
|
3 025
|
3 960
|
5 237
|
|
| Total Equity |
1 390
N/A
|
4 507
+224%
|
5 050
+12%
|
39 920
+691%
|
58 614
+47%
|
52 938
-10%
|
38 632
-27%
|
5 450
-86%
|
|
| Total Liabilities & Equity |
2 507
N/A
|
7 347
+193%
|
26 936
+267%
|
43 760
+62%
|
102 587
+134%
|
97 104
-5%
|
74 484
-23%
|
53 558
-28%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
|
| Preferred Shares Outstanding |
0
|
1
|
2
|
0
|
0
|
0
|
1
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
